These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4434670)

  • 1. Proceedings: Obstructive lipoprotein (LP-X) and liver disease.
    Magnani HN; Alaupovic P; Poley R
    Clin Sci Mol Med; 1974 Nov; 47(5):20P. PubMed ID: 4434670
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipoprotein-X (LP-X) in liver disease.
    Ritland S; Blomhoff JP; Elgjo K; Gjone E
    Scand J Gastroenterol; 1973; 8(2):155-60. PubMed ID: 4697077
    [No Abstract]   [Full Text] [Related]  

  • 3. Infantile obstructive cholangiopathy.
    McDonald PJ; Stehman FB; Stewart DR
    Am J Dis Child; 1979 May; 133(5):518-22. PubMed ID: 433876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative changes of serum lipoprotein-X after cholestyramine administration in infants with cholestatic biliary tract and liver disease.
    Poley JR; Caplan DB; Magnani HN; Alaupovic P; Smith EI; Campbell DP; Bhatia M; Burdelski M; Bojanovski D
    Eur J Clin Invest; 1978 Dec; 8(6):397-404. PubMed ID: 105912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative determination of the abnormal lipoprotein of cholestasis, LP-X, in liver disease.
    Ritland S
    Scand J Gastroenterol; 1975; 10(1):5-15. PubMed ID: 164686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatobiliary diseases in the newborn and infants].
    Markoff NG
    Hippokrates; 1976 Aug; 47(3):211-25. PubMed ID: 783096
    [No Abstract]   [Full Text] [Related]  

  • 7. Natural history of active chronic hepatitis. II. Pathology, pathogenesis and clinico-pathological correlation.
    Mistilis SP
    Australas Ann Med; 1968 Nov; 17(4):277-88. PubMed ID: 5701919
    [No Abstract]   [Full Text] [Related]  

  • 8. [The diagnosis of primary biliary cirrhosis (clinical, biochemical, immunological and morphological findings)].
    Brunner G; Vido I; Schmidt G
    Dtsch Med Wochenschr; 1972 Sep; 97(39):1448 passim. PubMed ID: 4560837
    [No Abstract]   [Full Text] [Related]  

  • 9. Autoantibodies in Autoimmune Liver Disease-Clinical and Diagnostic Relevance.
    Sebode M; Weiler-Normann C; Liwinski T; Schramm C
    Front Immunol; 2018; 9():609. PubMed ID: 29636752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies in neonatal hepatitis and biliary atresia. IV. Diagnosis.
    Thaler MM; Gellis SS
    Am J Dis Child; 1968 Sep; 116(3):280-4. PubMed ID: 5676648
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies in neonatal hepatitis and biliary atresia. I. Long-term prognosis of neonatal hepatitis.
    Thaler MM; Gellis SS
    Am J Dis Child; 1968 Sep; 116(3):257-61. PubMed ID: 5676646
    [No Abstract]   [Full Text] [Related]  

  • 12. Biliary atresia: the current state of confusion.
    Hayes DM
    Surg Clin North Am; 1973 Oct; 53(5):1257-73. PubMed ID: 4202004
    [No Abstract]   [Full Text] [Related]  

  • 13. The red cell peroxide hemolysis test in the differential diagnosis of obstructive jaundice in the newborn period.
    Lubin BH; Baehner RL; Schwartz E; Shohet SB; Nathan DG
    Pediatrics; 1971 Oct; 48(4):562-5. PubMed ID: 5114743
    [No Abstract]   [Full Text] [Related]  

  • 14. [Metabolic changes of cholestatic lipoprotein (LP-X) in the diagnosis of biliary atresia].
    Poley JR; Magnani HN; Alaupovic P
    Cesk Pediatr; 1978 Dec; 33(12):713-4. PubMed ID: 743758
    [No Abstract]   [Full Text] [Related]  

  • 15. Mitochondrial antibodies in extrahepatic biliary obstruction.
    Richer G; Viallet A
    Am J Dig Dis; 1974 Aug; 19(8):740-4. PubMed ID: 4843216
    [No Abstract]   [Full Text] [Related]  

  • 16. Lipoprotein-X and other tests in the diagnosis of obstructive jaundice in the infant.
    Lipsitz PJ; Yoss B; Schussheim A
    Am J Gastroenterol; 1979 Jan; 71(1):95-100. PubMed ID: 86296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The diagnostic significance of lipoprotein-X].
    Radzevich IM; Gromashevskaia LL; Tat'ianko NV
    Vrach Delo; 1990 Jan; (1):116-9. PubMed ID: 2330694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The significance of LP-X cholesterol in the differential diagnosis of cholestasis (author's transl)].
    Wieland H; Meissner-Heins H; Heins C; Seidel D
    Klin Wochenschr; 1982 Apr; 60(7):343-8. PubMed ID: 7078029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of suspected extrahepatic biliary atresia.
    Mowat AP; Psacharopoulos HT; Williams R
    Gut; 1975 Oct; 16(10):841. PubMed ID: 1205326
    [No Abstract]   [Full Text] [Related]  

  • 20. [The hepatopathy of antimitochondria antibodies. Criteria for its differentiation from primary biliary cirrhosis].
    Pedreira JD; Guardia J; Benet JM; Martin C; Esteban R; Martínez-Vázquez M; Bacardi R
    Rev Clin Esp; 1977 Nov; 147(3):303-6. PubMed ID: 305091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.